BUX.CN
BioMark Diagnostics Inc
Price:
0.3
CAD
Volume:
4,500
Canada | Manufacturing
No data available for this ticker
BUX.CN Probability of Bankruptcy
The Probability of Bankruptcy of BioMark Diagnostics Inc (BUX.CN) is 0% . This number represents the probability that BUX.CN will face financial distress in the next 24 months given its current fundamentals and market conditions.
Multiple factors are taken into account when calculating BUX.CN's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.
BUX.CN - Historical Solvency Measures
to of
Page of
BUX.CN - ESG ratings
ESG ratings are directly linked to the cost of capital and BUX.CN's ability to raise funding, both of which can significantly affect the probability of BioMark Diagnostics Inc going bankrupt.
ESG Score
0
Environment Score
0
Social Score
0
Governance Score
0
| Returns | |
| Historical Returns (5 day) | -1.96% |
| Historical Returns (MTD) | -7.41% |
| Historical Returns (YTD) | 25% |
| Historical Returns (13 week) | 4.17% |
| Historical Returns (26 week) | -18.03% |
| Historical Returns (52 week) | 55.56% |
| Efficiency | |
| Asset Turnover | 0.16 |
| Receiveable Turnover | 2.62 |
| Gross Margin | - |
| Operating Margin | - |
| Pretax Margin | - |
| Net Margin | - |
| Return on Asset (ROA) | -197.07 |
| Return on Equity (ROE) | -181.57 |
| Return on Investments (ROI) |
| Price Metrics | |
| Market Cap (M) | 31.5 |
| Enterprise Value (M) | 32 |
| 52 Week High | 0.32 |
| 52 Week Low | 0.18 |
| Beta | -0.44 |
| Average Volume (10 day) | 0.02 |
| Average Volume (3 month) | 0.01 |
| Price / Earnings (P/E) | - |
| Price / Sales (P/S) | 146.6 |
| Earnings | |
| EPS | -0.02 |
| Revenue CAGR (5 year) | 105.91% |
| Risk | |
| Current Ratio | 0.1 |
| Quick Ratio | 0.1 |
BUX.CN - Peer Comparisons
| Ticker | Company Name | Beta | Probability of Bankruptcy |
| a | |||
| PAHC | Phibro Animal Health Corp | 1.27 | 9.3% |
| HZNP | Horizon Therapeutics PLC | -0.28 | 7.7% |
| JAZZ | Jazz Pharmaceuticals PLC | 0.94 | 2.1% |
| TARO | Taro Pharmaceutical Industries Ltd | 0.81 | 79.5% |
| ZTS | Zoetis Inc | 0.43 | 6.5% |